======= RASD1 ======= == Gene Information == * **Official Symbol**: RASD1 * **Official Name**: ras related dexamethasone induced 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51655|51655]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y272|Q9Y272]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RASD1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RASD1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605550|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the Ras superfamily of small GTPases and is induced by dexamethasone. The encoded protein is an activator of G-protein signaling and acts as a direct nucleotide exchange factor for Gi-Go proteins. This protein interacts with the neuronal nitric oxide adaptor protein CAPON, and a nuclear adaptor protein FE65, which interacts with the Alzheimer's disease amyloid precursor protein. This gene may play a role in dexamethasone-induced alterations in cell morphology, growth and cell-extracellular matrix interactions. Epigenetic inactivation of this gene is closely correlated with resistance to dexamethasone in multiple myeloma cells. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2011]. * **UniProt Summary**: Small GTPase. Negatively regulates the transcription regulation activity of the APBB1/FE65-APP complex via its interaction with APBB1/FE65 (By similarity). {ECO:0000250}. |Arf| |Miro| |Ras| |nitric oxide mediated signal transduction| |sarcoplasmic reticulum| |GTPase activity| |second-messenger-mediated signaling| |GTP binding| |perinuclear region of cytoplasm| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |G protein-coupled receptor signaling pathway| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |intracellular signal transduction| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp455|Benzoate 10000μM R08 exp455]]|1.83| |[[:results:exp279|D-Fructose 10000μM R06 exp279]]|2.03| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.411| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13457 * **Expression level (log2 read counts)**: 4.65 {{:chemogenomics:nalm6 dist.png?nolink |}}